Renal artery stenosis in kidney transplants: Assessment of the risk factors

Vascular Health and Risk Management

Volumn 7, Issue 1, 2011, Pages 503-507

  Etemadi, Jalal ^a   Rahbar, Khosro ^b   Haghighi, Ali Nobakht ^b   Bagheri, Nazila ^b   Falaknazi, Kianoosh ^b   Ardalan, Mohammad Reza ^a   Ghabili, Kamyar ^c   Shoja, Mohammadali M ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerosis; Calcium phosphate product; Low density lipoprotein; Transplant renal artery stenosis; Uric acid

Indexed keywords

ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; CALCIUM; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHORUS; URIC ACID;

ADULT; ARTICLE; BLOOD; DRUG RESISTANCE; FEMALE; HUMAN; IRAN; KIDNEY ARTERY STENOSIS; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; RENOVASCULAR HYPERTENSION; RISK ASSESSMENT; RISK FACTOR; TIME;

ADULT; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; CALCIUM; CHOLESTEROL, LDL; DRUG RESISTANCE; FEMALE; HUMANS; HYPERTENSION, RENOVASCULAR; IRAN; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PHOSPHORUS; RENAL ARTERY OBSTRUCTION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; URIC ACID;

EID: 84856054344     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S19645     Document Type: Article

References (20)

1. Ardalan MR, Tarzamni MK, Shoja MM, et al. Black tea improves endothelial function in renal transplant recipients. Transplant Proc. 2007;39:1139-1142.
2. Fervenza FC, Lafayette RA, Alfrey EJ, Petersen J. Renal artery stenosis in kidney transplants. Am J Kidney Dis. 1998;31:142-148.
3. Patel NH, Jindal RM, Wilkin T, et al. Renal arterial stenosis in renal allografts: retrospective study of predisposing factors and outcome after percutaneous transluminal angioplasty. Radiology. 2001;219:663-667.
4. Ardalan MR, Shoja MM, Tubbs RS, Ghabili K. Transplant renal artery stenosis associated with acute cytomegalovirus infection: resolution following ganciclovir administration. Ren Fail. 2009;31: 982-984.
5. Bruno S, Remuzzi G, Ruggenenti P. Transplant renal artery stenosis. J Am Soc Nephrol. 2004;15:134-141.
6. Audard V, Matignon M, Hemery F, et al. Risk factors and long-term outcome of transplant renal artery stenosis in adult recipients after treatment by percutaneous transluminal angioplasty. Am J Transplant. 2006;6:95-99.
7. Becker BN, Odorico JS, Becker YT, et al. Peripheral vascular disease and renal transplant artery stenosis: a reappraisal of transplant renovascular disease. Clin Transplant. 1999;13:349-355.
8. Pouria S, State OI, Wong W, Hendry BM. CMV infection is associated with transplant renal artery stenosis. QJM. 1998;91:185-189.
9. Fernández-Nájera JE, Beltrán S, Aparicio M, et al. Transplant renal artery stenosis: association with acute vascular rejection. Transplant Proc. 2006;38:2404-2405.
10. Buturovic-Ponikvar J. Renal transplant artery stenosis. Nephrol Dial Transplant. 2003;18:v74-v77.
11. Schaeffner ES, Födinger M, Kramar R, Sunder-Plassmann G, Winkelmayer WC. Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients. Transpl Int. 2007;20:247-255.
12. Phan O, Ivanovski O, Nguyen-Khoa T, et al. Sevelamer prevents uremiaenhanced atherosclerosis progression in apolipoprotein E-deficient mice. Circulation. 2005;112:2875-2882.
13. Movilli E, Feliciani A, Camerini C, et al. A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. Nephron Clin Pract. 2005;101: c161-c167.
14. Brancaccio D, Tetta C, Gallieni M, Panichi V. Inflammation, CRP, calcium overload and a high calcium-phosphate product: a "liaison dangereuse. " Nephrol Dial Transplant. 2002;17:201-203.
15. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Guideline 6. Serum Calcium and Calcium-Phosphorus Product. Available from: http://www.kidney.org/ professionals/kdoqi/guidelines_bone/guide6.htm. Accessed June 16, 2011.
16. Scoble JE, de Takats D, Ostermann ME, et al. Lipid prof iles in patients with atherosclerotic renal artery stenosis. Nephron. 1999;83:117-121.
17. Ruiz MC, Medina A, Moreno JM, et al. Relationship between oxidative stress parameters and atherosclerotic signs in the carotid artery of stable renal transplant patients. Transplant Proc. 2005;37:3796-3798.
18. Paragh G, Asztalos L, Seres I, et al. Serum paraoxonase activity changes in uremic and kidney-transplanted patients. Nephron. 1999;83: 126-131.
19. Moreno JM, Ruiz MC, Ruiz N, et al. Modulation factors of oxidative status in stable renal transplantation. Transplant Proc. 2005;37: 1428-1430.
20. Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41:1183-1190.